Society guideline links: Contraception

Introduction — 

This topic includes links to society and government-sponsored guidelines from selected countries and regions around the world. We will update these links periodically; newer versions of some guidelines may be available on each society's website. Some societies may require users to log in to access their guidelines.

The recommendations in the following guidelines may vary from those that appear in UpToDate topic reviews. Readers who are looking for UpToDate topic reviews should use the UpToDate search box to find the relevant content.

International

●International Society for Heart and Lung Transplantation (ISHLT): Expert consensus statement on reproductive health after thoracic transplantation (2023)

●World Health Organization (WHO): Abortion care guideline (2022)

●WHO: Family planning – A global handbook for providers (2022)

●WHO: Guideline on self-care interventions for health and well-being, revision (2022)

●WHO: Recommendations on self-care interventions – Self-administration of injectable contraception, update (2022)

●International Federation of Gynecology and Obstetrics (FIGO): Statement on post-abortion contraception, including long-acting reversible contraceptives (2021)

●FIGO: Statement on protecting and promoting sexual and reproductive health services for young women and girls (2021)

●Academy of Breastfeeding Medicine (ABM): Clinical protocol #13 – Contraception during breastfeeding, revised (2015)

●WHO: Guideline on medical eligibility criteria for contraceptive use, 5th edition (2015)

●WHO: Guidance and recommendations on ensuring human rights in the provision of contraceptive information and services (2014)

●WHO: Guidelines on preventing early pregnancy and poor reproductive outcomes among adolescents in developing countries (2011)

Canada

●Canadian Paediatric Society (CPS): Position statement on contraceptive care for Canadian youth (2018, reaffirmed 2024)

●Society of Obstetricians and Gynecologists of Canada (SOGC): Clinical practice guideline on cannabis use throughout women's lifespans – Part 1: Fertility, contraception, menopause, and pelvic pain (2022)

●SOGC: Committee opinion on coercion free contraceptive care (2021)

●SOGC: Clinical practice guideline on menstrual suppression in special circumstances (2014, reaffirmed 2019)

●SOGC: Canadian contraception consensus – Combined hormonal contraception (2017)

●SOGC: Addendum to the Canadian consensus on contraception – Emergency contraception: 1) Excluding pre-existing pregnancy when inserting copper IUD and 2) Initiation of hormonal contraception after emergency contraception (2016)

•SOGC: Canadian contraception consensus – Emergency contraception (2015)

●SOGC: Canadian contraception consensus – Intrauterine contraception (2016)

●SOGC: Canadian contraception consensus – Progestin-only contraception (2016)

●SOGC: Canadian contraception consensus – Barrier methods (2015)

●SOGC: Canadian contraception consensus – Contraception in Canada (2015)

●SOGC: Canadian contraception consensus – Contraceptive care and access (2015)

●SOGC: Canadian contraception consensus – Natural family planning (2015)

●SOGC: Canadian contraception consensus – Permanent contraception (2015)

●SOGC: Committee opinion on best practices to minimize risk of infection with intrauterine device insertion (2014)

United States

●Society for Adolescent Health and Medicine (SAHM): Adolescent and young adult clinical care resources – Sexual and reproductive health

●Society of Family Planning (SFP): Clinical guidance

●American College of Obstetricians and Gynecologists (ACOG): Committee opinion on counseling adolescents about contraception (2017, reaffirmed 2025)

●ACOG: Committee opinion on over-the-counter access to hormonal contraception (2019, reaffirmed 2025)

●ACOG: Committee opinion on access to postabortion contraception (2021, reaffirmed 2024)

●ACOG: Committee opinion on access to postpartum sterilization (2021, reaffirmed 2024)

●ACOG: Committee opinion on clinical challenges of long-acting reversible contraceptive methods (2016, reaffirmed 2024)

●ACOG: Committee opinion on health care for transgender and gender diverse individuals (2021, reaffirmed 2024)

●ACOG: Committee opinion on options for prevention and management of menstrual bleeding in adolescent patients undergoing cancer treatment (2021, reaffirmed 2024)

●ACOG: Committee opinion on reproductive health care for incarcerated pregnant, postpartum, and nonpregnant individuals (2021, reaffirmed 2024)

●ACOG: Committee statement on permanent contraception – Ethical issues and considerations (2024)

●ACOG: Practice advisory on hormonal contraception and risk of breast cancer (2018, reaffirmed 2024)

●ACOG: Practice bulletin on long-acting reversible contraception – Implants and intrauterine devices (2017, reaffirmed 2024)

●Centers for Disease Control and Prevention (CDC): Contraceptive guidance for health care providers (2024)

●CDC: US medical eligibility criteria for contraceptive use (2024)

●CDC: US selected practice recommendations for contraceptive use (2024)

●US Office of Population Affairs (OPA): Recommendations for providing quality family planning services in the United States, revised (2024)

●ACOG: Committee opinion on comprehensive sexuality education (2016, reaffirmed 2023)

●ACOG: Committee opinion on depot medroxyprogesterone acetate and bone effects (2014, reaffirmed 2023)

●ACOG: Committee statement on improving access to intrauterine devices and contraceptive implants (2023)

●ACOG: Clinical consensus on general approaches to medical management of menstrual suppression (2022)

●ACOG: Committee opinion on access to contraception (2015, reaffirmed 2022)

●ACOG: Committee statement on patient-centered contraceptive counseling (2022)

●US Food and Drug Administration (FDA): Essure permanent birth control (updated 2022)

●Women's Preventive Services Initiative (WPSI): Clinical recommendations on contraception (2016, updated 2022)

●American Academy of Pediatrics (AAP): Clinical report on contraception for HIV-infected adolescents (2016, reaffirmed 2021)

●AAP: Policy statement on contraception for adolescents (2014, reaffirmed 2021)

●ACOG: Committee opinion on adolescents and long-acting reversible contraception – Implants and intrauterine devices (2018, reaffirmed 2021)

●ACOG: Committee opinion on optimizing postpartum care (2018, reaffirmed 2021)

●ACOG and Society for Maternal-Fetal Medicine (SMFM): Obstetric care consensus on interpregnancy care (2019, reaffirmed 2021)

●AAP: Clinical report on long-acting reversible contraception – Specific issues for adolescents (2020)

●AAP: Policy statement on barrier protection use by adolescents during sexual activity (2020)

●American College of Rheumatology (ACR): Guideline for the management of reproductive health in rheumatic and musculoskeletal diseases (2020)

●AAP: Policy statement on emergency contraception (2019)

●ACOG: Practice bulletin on the benefits and risks of sterilization (2019)

●SMFM: Consult series on immediate postpartum long-acting reversible contraception for women at high risk for medical complications (2019)

United Kingdom

●Faculty of Sexual and Reproductive Healthcare (FSRH): Standards and guidance

●Royal College of Obstetricians and Gynaecologists (RCOG): Best practice in post-abortion contraception (2022)

●National Institute for Health and Care Excellence (NICE): Clinical guideline on long-acting reversible contraception (2005, updated 2019)

●NICE: Quality standard on contraception (2016)

●RCOG: Consent advice on female sterilisation (2016)

●NICE: Public health guideline on contraceptive services for under 25s (2014)

●RCOG and FSRH: Clinical guidance for the management of unscheduled bleeding in women using hormonal contraception (2009)

Australia-New Zealand

●Royal Australian and New Zealand College of Obstetricians and Gynaecologists (RANZCOG): Clinical guideline on contraception (2024)

Japan

●[In English] Japan Society of Obstetrics and Gynecology (JSOG) and Japan Association of Obstetricians and Gynecologists (JAOG): Guideline for gynecological practice in Japan, 2023 edition (published 2024)

●[In Japanese] JSOG and JAOG: Obstetrics and gynecology clinical practice guidelines – Gynecology outpatient edition (2023)

●[In Japanese] JSOG: OC/LEP – Low-dose oral contraceptives, low-dose estrogen/progestin guideline, 2020 (published 2021)

●[In Japanese] JSOG: Guidelines for proper use of emergency contraception (2016)